{"id":32679,"date":"2021-03-15T16:59:02","date_gmt":"2021-03-15T15:59:02","guid":{"rendered":"https:\/\/www.essenscia.be\/?p=32679"},"modified":"2021-03-19T17:24:34","modified_gmt":"2021-03-19T16:24:34","slug":"gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre","status":"publish","type":"post","link":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/","title":{"rendered":"GSK investit 330 millions d&rsquo;euros sur son site de production de vaccins \u00e0 Wavre"},"content":{"rendered":"<p><span class=\"intro-paragraph\">L\u2019entreprise pharmaceutique britannique GSK investit 330 millions d&rsquo;euros sur son site de Wavre, le plus grand site de production de vaccins au monde. L&rsquo;investissement sera r\u00e9parti sur deux projets : la cr\u00e9ation d&rsquo;une nouvelle unit\u00e9 de lyophilisation et l&rsquo;extension d&rsquo;un b\u00e2timent de recherche et d\u00e9veloppement technique.<\/span><\/p>\n<p>Gr\u00e2ce \u00e0 cet investissement, GSK souhaite faire de son site de Wavre un centre d&rsquo;expertise en mati\u00e8re de lyophilisation. Le site jouera donc un r\u00f4le important dans la production de vaccins lyophilis\u00e9s. L\u2019entreprise pharmaceutique agrandit \u00e9galement un b\u00e2timent existant destin\u00e9 \u00e0 la recherche et au d\u00e9veloppement technique. Cette extension accueillera les diff\u00e9rentes \u00e9quipes du d\u00e9partement en un m\u00eame lieu, renfor\u00e7ant encore l&rsquo;ancrage de cette expertise belge.<\/p>\n<p>Ce nouvel investissement de GSK s\u2019ajoute aux investissements annonc\u00e9s pr\u00e9c\u00e9demment, d&rsquo;un montant total de quelque 600 millions d&rsquo;euros, sur son site de production \u00e0 Wavre et sur son site historique de recherche et d\u00e9veloppement \u00e0 Rixensart.<\/p>\n<blockquote><p>\u00ab\u00a0Il s&rsquo;agit d&rsquo;un signal de confiance pour l&rsquo;avenir industriel de notre pays\u00a0\u00bb<\/p>\n<p><span class=\"quote-author\"><strong>Fr\u00e9d\u00e9ric Druck, administrateur d\u00e9l\u00e9gu\u00e9 d\u2019essenscia wallonie<\/strong><\/span><\/p><\/blockquote>\n<p><strong>Fr\u00e9d\u00e9ric Druck<\/strong>, administrateur d\u00e9l\u00e9gu\u00e9 d\u2019essenscia wallonie : <em>\u00ab Gr\u00e2ce \u00e0 cet investissement cons\u00e9quent, GSK renforce sa forte pr\u00e9sence dans notre pays, tant en termes de production que d&rsquo;innovation. L\u2019une des principales entreprises pharmaceutiques au monde envoie ainsi un signal de confiance pour l&rsquo;avenir industriel de notre pays. Nulle part au monde on ne produit autant de vaccins par habitant que dans notre pays. Cet investissement nous permet de renforcer cette position de leader, gr\u00e2ce \u00e0 la production de nouveaux vaccins et au d\u00e9veloppement de nouvelles technologies. \u00bb<\/em><\/p>\n<p><a href=\"https:\/\/www.essenscia.be\/wp-content\/uploads\/2021\/03\/210315_communique_gsk-continue-a-investir-massivement-en-belgique.pdf\" target=\"_blank\" rel=\"noopener\">Lire le communiqu\u00e9 de presse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019entreprise pharmaceutique britannique GSK investit 330 millions d&rsquo;euros sur son site de Wavre, le plus grand site de production de vaccins au monde. L&rsquo;investissement sera r\u00e9parti sur deux projets : la cr\u00e9ation d&rsquo;une nouvelle unit\u00e9 de lyophilisation et l&rsquo;extension d&rsquo;un b\u00e2timent de recherche et d\u00e9veloppement technique.<\/p>\n","protected":false},"author":1550,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[182,733],"communication":[148],"expertise":[985],"class_list":["post-32679","post","type-post","status-publish","format-standard","category-investissements","category-pharma-fr","communication-actu-des-entreprises","expertise-communication-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GSK investit 330 millions d&#039;euros sur son site de production de vaccins \u00e0 Wavre - essenscia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK investit 330 millions d&#039;euros sur son site de production de vaccins \u00e0 Wavre - essenscia\" \/>\n<meta property=\"og:description\" content=\"L\u2019entreprise pharmaceutique britannique GSK investit 330 millions d&#039;euros sur son site de Wavre, le plus grand site de production de vaccins au monde. L&#039;investissement sera r\u00e9parti sur deux projets : la cr\u00e9ation d&#039;une nouvelle unit\u00e9 de lyophilisation et l&#039;extension d&#039;un b\u00e2timent de recherche et d\u00e9veloppement technique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/\" \/>\n<meta property=\"og:site_name\" content=\"essenscia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/essenscia\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-15T15:59:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T16:24:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.essenscia.be\/wp-content\/uploads\/2020\/02\/200206_CP_restructuration_GSK_image_Wavre-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"506\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gert JADDOULLE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@essenscia\" \/>\n<meta name=\"twitter:site\" content=\"@essenscia\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gert JADDOULLE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/\"},\"author\":{\"name\":\"Gert JADDOULLE\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#\\\/schema\\\/person\\\/53b8ebcbcc893a0efab4dee8599541fa\"},\"headline\":\"GSK investit 330 millions d&rsquo;euros sur son site de production de vaccins \u00e0 Wavre\",\"datePublished\":\"2021-03-15T15:59:02+00:00\",\"dateModified\":\"2021-03-19T16:24:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/\"},\"wordCount\":310,\"publisher\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#organization\"},\"articleSection\":[\"Investissements\",\"Pharma\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/\",\"url\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/\",\"name\":\"GSK investit 330 millions d'euros sur son site de production de vaccins \u00e0 Wavre - essenscia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#website\"},\"datePublished\":\"2021-03-15T15:59:02+00:00\",\"dateModified\":\"2021-03-19T16:24:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.essenscia.be\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communication\",\"item\":\"https:\\\/\\\/www.essenscia.be\\\/fr\\\/?expertise=communication-fr\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"GSK investit 330 millions d&rsquo;euros sur son site de production de vaccins \u00e0 Wavre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#website\",\"url\":\"https:\\\/\\\/www.essenscia.be\\\/\",\"name\":\"essenscia\",\"description\":\"Belgian Federation for Chemistry and Life Sciences Industries\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.essenscia.be\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#organization\",\"name\":\"essenscia - Belgian Federation for Chemistry and Life Sciences Industries\",\"url\":\"https:\\\/\\\/www.essenscia.be\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.essenscia.be\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/essenscia_logo_header.png\",\"contentUrl\":\"https:\\\/\\\/www.essenscia.be\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/essenscia_logo_header.png\",\"width\":200,\"height\":161,\"caption\":\"essenscia - Belgian Federation for Chemistry and Life Sciences Industries\"},\"image\":{\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/essenscia\\\/\",\"https:\\\/\\\/x.com\\\/essenscia\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/essenscia\",\"https:\\\/\\\/nl.wikipedia.org\\\/wiki\\\/Essenscia\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.essenscia.be\\\/#\\\/schema\\\/person\\\/53b8ebcbcc893a0efab4dee8599541fa\",\"name\":\"Gert JADDOULLE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g\",\"caption\":\"Gert JADDOULLE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GSK investit 330 millions d'euros sur son site de production de vaccins \u00e0 Wavre - essenscia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/","og_locale":"fr_FR","og_type":"article","og_title":"GSK investit 330 millions d'euros sur son site de production de vaccins \u00e0 Wavre - essenscia","og_description":"L\u2019entreprise pharmaceutique britannique GSK investit 330 millions d'euros sur son site de Wavre, le plus grand site de production de vaccins au monde. L'investissement sera r\u00e9parti sur deux projets : la cr\u00e9ation d'une nouvelle unit\u00e9 de lyophilisation et l'extension d'un b\u00e2timent de recherche et d\u00e9veloppement technique.","og_url":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/","og_site_name":"essenscia","article_publisher":"https:\/\/www.facebook.com\/essenscia\/","article_published_time":"2021-03-15T15:59:02+00:00","article_modified_time":"2021-03-19T16:24:34+00:00","og_image":[{"width":800,"height":506,"url":"https:\/\/www.essenscia.be\/wp-content\/uploads\/2020\/02\/200206_CP_restructuration_GSK_image_Wavre-1.jpg","type":"image\/jpeg"}],"author":"Gert JADDOULLE","twitter_card":"summary_large_image","twitter_creator":"@essenscia","twitter_site":"@essenscia","twitter_misc":{"\u00c9crit par":"Gert JADDOULLE","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/#article","isPartOf":{"@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/"},"author":{"name":"Gert JADDOULLE","@id":"https:\/\/www.essenscia.be\/#\/schema\/person\/53b8ebcbcc893a0efab4dee8599541fa"},"headline":"GSK investit 330 millions d&rsquo;euros sur son site de production de vaccins \u00e0 Wavre","datePublished":"2021-03-15T15:59:02+00:00","dateModified":"2021-03-19T16:24:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/"},"wordCount":310,"publisher":{"@id":"https:\/\/www.essenscia.be\/#organization"},"articleSection":["Investissements","Pharma"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/","url":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/","name":"GSK investit 330 millions d'euros sur son site de production de vaccins \u00e0 Wavre - essenscia","isPartOf":{"@id":"https:\/\/www.essenscia.be\/#website"},"datePublished":"2021-03-15T15:59:02+00:00","dateModified":"2021-03-19T16:24:34+00:00","breadcrumb":{"@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.essenscia.be\/fr\/gsk-investit-330-millions-deuros-sur-son-site-de-production-de-vaccins-a-wavre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.essenscia.be\/"},{"@type":"ListItem","position":2,"name":"Communication","item":"https:\/\/www.essenscia.be\/fr\/?expertise=communication-fr"},{"@type":"ListItem","position":3,"name":"GSK investit 330 millions d&rsquo;euros sur son site de production de vaccins \u00e0 Wavre"}]},{"@type":"WebSite","@id":"https:\/\/www.essenscia.be\/#website","url":"https:\/\/www.essenscia.be\/","name":"essenscia","description":"Belgian Federation for Chemistry and Life Sciences Industries","publisher":{"@id":"https:\/\/www.essenscia.be\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.essenscia.be\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.essenscia.be\/#organization","name":"essenscia - Belgian Federation for Chemistry and Life Sciences Industries","url":"https:\/\/www.essenscia.be\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.essenscia.be\/#\/schema\/logo\/image\/","url":"https:\/\/www.essenscia.be\/wp-content\/uploads\/2019\/04\/essenscia_logo_header.png","contentUrl":"https:\/\/www.essenscia.be\/wp-content\/uploads\/2019\/04\/essenscia_logo_header.png","width":200,"height":161,"caption":"essenscia - Belgian Federation for Chemistry and Life Sciences Industries"},"image":{"@id":"https:\/\/www.essenscia.be\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/essenscia\/","https:\/\/x.com\/essenscia","https:\/\/www.linkedin.com\/company\/essenscia","https:\/\/nl.wikipedia.org\/wiki\/Essenscia"]},{"@type":"Person","@id":"https:\/\/www.essenscia.be\/#\/schema\/person\/53b8ebcbcc893a0efab4dee8599541fa","name":"Gert JADDOULLE","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4233b03603d075189e55d3a1726f61713b16b27ab76872c80d0278e31316ea53?s=96&d=mm&r=g","caption":"Gert JADDOULLE"}}]}},"_links":{"self":[{"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/posts\/32679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/users\/1550"}],"replies":[{"embeddable":true,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/comments?post=32679"}],"version-history":[{"count":0,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/posts\/32679\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/media?parent=32679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/categories?post=32679"},{"taxonomy":"communication","embeddable":true,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/communication?post=32679"},{"taxonomy":"expertise","embeddable":true,"href":"https:\/\/www.essenscia.be\/fr\/wp-json\/wp\/v2\/expertise?post=32679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}